Biogen 221AD305
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer’s Disease.
